Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 239

1.

Measuring therapy-induced peripheral neuropathy: preliminary development and validation of the Treatment-induced Neuropathy Assessment Scale (TNAS).

Mendoza TR, Wang XS, Williams LA, Shi Q, Vichaya EG, Dougherty PM, Thomas SK, Yucel E, Bastida CC, Woodruff JF, Cleeland CS.

J Pain. 2015 Jul 22. pii: S1526-5900(15)00763-4. doi: 10.1016/j.jpain.2015.07.002. [Epub ahead of print]

PMID:
26210041
2.

The efficacy of the natural clay, Calcium Aluminosilicate Anti-Diarrheal (CASAD), in reducing medullary thyroid cancer-related diarrhea and its effects on quality of life: a pilot study.

Dadu R, Hu MI, Cleeland CS, Busaidy N, Habra MA, Waguespack SG, Sherman SI, Ying AK, Fox P, Cabanillas M.

Thyroid. 2015 Jul 22. [Epub ahead of print]

PMID:
26200040
3.

Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory.

Fagundes CP, Shi Q, Vaporciyan AA, Rice DC, Popat KU, Cleeland CS, Wang XS.

J Thorac Cardiovasc Surg. 2015 May 28. pii: S0022-5223(15)00871-5. doi: 10.1016/j.jtcvs.2015.05.057. [Epub ahead of print]

PMID:
26088408
4.

Symptom management of gynecologic cancers: refocusing on the forest.

Cleeland CS, Rose SL.

Gynecol Oncol. 2015 Mar;136(3):413-4. doi: 10.1016/j.ygyno.2015.01.555. No abstract available.

PMID:
25752571
5.

Automated pain intervention for underserved minority women with breast cancer.

Anderson KO, Palos GR, Mendoza TR, Cleeland CS, Liao KP, Fisch MJ, Garcia-Gonzalez A, Rieber AG, Nazario LA, Valero V, Hahn KM, Person CL, Payne R.

Cancer. 2015 Jun 1;121(11):1882-90. doi: 10.1002/cncr.29204. Epub 2015 Feb 24.

PMID:
25711974
6.

Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents.

Patrick DL, Cleeland CS, von Moos R, Fallowfield L, Wei R, Öhrling K, Qian Y.

Support Care Cancer. 2015 Apr;23(4):1157-68. doi: 10.1007/s00520-014-2525-4. Epub 2014 Dec 23. Review.

PMID:
25533578
7.

Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.

Shi Q, Wang XS, Li G, Shah ND, Orlowski RZ, Williams LA, Mendoza TR, Cleeland CS.

Cancer. 2015 Apr 1;121(7):1138-46. doi: 10.1002/cncr.29154. Epub 2014 Dec 2.

PMID:
25469832
8.

The symptom burden of treatment-naive patients with head and neck cancer.

Hanna EY, Mendoza TR, Rosenthal DI, Gunn GB, Sehra P, Yucel E, Cleeland CS.

Cancer. 2015 Mar 1;121(5):766-73. doi: 10.1002/cncr.29097. Epub 2014 Nov 4.

PMID:
25369213
9.

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D.

J Natl Cancer Inst. 2014 Sep 29;106(9). pii: dju244. doi: 10.1093/jnci/dju244. Print 2014 Sep.

PMID:
25265940
10.

Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.

Chu SH, Lee YJ, Lee ES, Geng Y, Wang XS, Cleeland CS.

Support Care Cancer. 2015 Feb;23(2):513-24. doi: 10.1007/s00520-014-2408-8. Epub 2014 Sep 26.

PMID:
25256375
11.

Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma.

Wang XS, Shi Q, Williams LA, Shah ND, Mendoza TR, Cohen EN, Reuben JM, Cleeland CS, Orlowski RZ.

Leuk Lymphoma. 2015 May;56(5):1335-41. doi: 10.3109/10428194.2014.956313. Epub 2014 Nov 20.

PMID:
25248883
12.

Impact of symptom burden on work-related abilities in patients with locally recurrent or metastatic breast cancer: Results from a substudy of the VIRGO observational cohort study.

Cleeland CS, Mayer M, Dreyer NA, Yim YM, Yu E, Su Z, Mun Y, Sloan JA, Kaufman PA.

Breast. 2014 Dec;23(6):763-9. doi: 10.1016/j.breast.2014.08.004. Epub 2014 Sep 3.

PMID:
25193423
13.

A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy.

de Carvalho Barbosa M, Kosturakis AK, Eng C, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Wang XS, Cleeland CS, Dougherty PM.

Cancer Res. 2014 Nov 1;74(21):5955-62. doi: 10.1158/0008-5472.CAN-14-2060. Epub 2014 Sep 2.

PMID:
25183707
14.

Socioeconomic status is associated with depressive severity among patients with advanced non-small-cell lung cancer: treatment setting and minority status do not make a difference.

Fagundes C, Jones D, Vichaya E, Lu C, Cleeland CS.

J Thorac Oncol. 2014 Oct;9(10):1459-63. doi: 10.1097/JTO.0000000000000284.

PMID:
25170640
15.

Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density.

Kosturakis AK, He Z, Li Y, Boyette-Davis JA, Shah N, Thomas SK, Zhang H, Vichaya EG, Wang XS, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Cleeland CS, Dougherty PM.

J Clin Oncol. 2014 Oct 1;32(28):3156-62. doi: 10.1200/JCO.2013.54.5418. Epub 2014 Aug 25.

PMID:
25154818
16.

Nomogram for predicting symptom severity during radiation therapy for head and neck cancer.

Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB.

Otolaryngol Head Neck Surg. 2014 Oct;151(4):619-26. doi: 10.1177/0194599814545746. Epub 2014 Aug 7.

PMID:
25104816
17.

Symptom burden in hematologic malignancies.

Cleeland CS, Williams LA.

Blood. 2014 Jun 12;123(24):3686-7. doi: 10.1182/blood-2014-03-558981. No abstract available.

18.

Measuring symptoms as a critical component of drug development and evaluation in hematological diseases.

Williams LA, Yucel E, Cortes JE, Cleeland CS.

Clin Investig (Lond). 2013 Dec 1;3(12):1127-1138.

19.

Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study.

Schmidt H, Cleeland CS, Bauer A, Landenberger M, Jahn P.

J Pain Symptom Manage. 2015 Jan;49(1):117-25. doi: 10.1016/j.jpainsymman.2014.04.007. Epub 2014 May 23.

PMID:
24858739
20.

Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II study.

Martin-Broto J, Cleeland CS, Glare PA, Engellau J, Skubitz KM, Blum RH, Ganjoo KN, Staddon A, Dominkus M, Feng A, Qian Y, Braun A, Jacobs I, Chung K, Atchison C.

Acta Oncol. 2014 Sep;53(9):1173-9. doi: 10.3109/0284186X.2014.910313. Epub 2014 May 19.

PMID:
24834795
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk